Toujeo in 2026: What's Going On With Availability?

If you depend on Toujeo to manage your diabetes, the last couple of years have probably felt like a roller coaster. Reports of pharmacies being out of stock, long wait times for refills, and confusing information about shortages have left many patients anxious and frustrated.

So what's the real situation with Toujeo in 2026? Let's break it down with the latest information.

Is Toujeo Still in Shortage?

As of early 2026, Toujeo is not listed as formally in shortage by the FDA. Sanofi continues to manufacture both the Toujeo SoloStar and Toujeo Max SoloStar pens.

However, the reality on the ground is more complicated. The broader Insulin Glargine market has been under significant strain. The ASHP (American Society of Health-System Pharmacists) has tracked Insulin Glargine supply issues with updates through January 2026, and many patients continue to report intermittent availability problems at individual pharmacies.

The bottom line: Toujeo is being made and shipped, but you may still encounter spotty availability depending on where you live and which pharmacy you use.

Why Has Toujeo Been Hard to Find?

Several factors have converged to create availability challenges:

Semglee Discontinuation

In January 2025, Semglee (a biosimilar Insulin Glargine U-100 made by Biocon/Mylan) was phased out. Many patients who had been using Semglee needed to switch to other Insulin Glargine products, dramatically increasing demand for brands like Toujeo, Lantus, and Basaglar.

Insurance Formulary Shifts

In response to the Semglee discontinuation, insurers like Blue Cross NC added Toujeo to preferred formularies — in some cases without prior authorization. While this improved access on paper, it also drove up prescription volume faster than pharmacies could restock.

Supply Chain Complexity

Insulin manufacturing is a complex biological process involving fermentation, purification, and cold-chain distribution. Any disruption at any point can create delays that ripple through the system for weeks or months.

For a more detailed look at all the factors, see our full explainer: Why Is Toujeo So Hard to Find?

How Much Does Toujeo Cost in 2026?

Cost remains a significant concern for many patients. Here's what you can expect:

• Retail (cash) price: Approximately $175-$200 for a single Toujeo SoloStar pen (1.5 mL), or $450-$550 for a box of Toujeo Max SoloStar pens. Monthly costs without insurance can reach $350 to $550+ depending on your dose.
• With insurance: Most commercial plans and Medicare Part D cover Toujeo, though it's often on a non-preferred brand tier (Tier 3-4) with copays ranging from $30-$100+ per month.
• Sanofi Valyou Savings: Uninsured patients or insured patients paying cash can get Toujeo for $35 per 30-day supply through Sanofi's Insulins Valyou Savings Program.
• Sanofi Copay Card: Commercially insured patients may pay $0 copay with the Sanofi Insulins Copay Savings Card.
• Medicare: As of 2025, Medicare Part D has an annual out-of-pocket cap of $2,000, which helps patients with high insulin costs.

For the complete breakdown of savings options, read our guide: How to Save Money on Toujeo in 2026.

Are There New Options for Patients?

The insulin landscape has been evolving. Here are some developments relevant to Toujeo patients in 2026:

Unbranded Insulin Glargine U-300

Sanofi now offers an unbranded (authorized generic) version of Toujeo — marketed as Insulin Glargine U-300 SoloStar and Insulin Glargine U-300 Max SoloStar. It's the exact same medication in the same pen, just without the Toujeo brand name. It's also eligible for the $35/month Valyou Savings Program.

Alternative Long-Acting Insulins

If Toujeo remains unavailable to you, there are effective alternatives:

• Tresiba (Insulin Degludec) — ultra-long-acting, up to 42-hour duration
• Lantus (Insulin Glargine U-100) — same active ingredient, lower concentration
• Basaglar (Insulin Glargine U-100 biosimilar) — often more affordable
• Levemir (Insulin Detemir) — long-acting, may require twice-daily dosing

Read the full comparison: Alternatives to Toujeo.

How to Find Toujeo in Stock Right Now

Here are your best strategies:

1. Use Medfinder: Search for Toujeo at medfinder.com to check real-time pharmacy availability near your zip code.
2. Try independent pharmacies: They often have more flexible sourcing than large chains.
3. Ask about special orders: Your pharmacy can request Toujeo from their wholesaler even if it's not currently on the shelf.
4. Consider mail-order: Many insurance plans offer mail-order pharmacy with 90-day supplies.
5. Refill early: Don't wait until your last pen. Fill a few days early when your insurance allows.

For a detailed walkthrough, check out: How to Find Toujeo in Stock Near You.

Final Thoughts

The Toujeo shortage situation in 2026 is nuanced. While it's not formally in shortage, real-world availability hasn't been perfectly smooth. The good news is that Sanofi is still manufacturing it, savings programs make it affordable, and there are proven alternatives if you need a backup plan.

Stay proactive: use Medfinder to track availability, take advantage of savings programs, and keep an open dialogue with your prescriber. If you're a healthcare provider, see our provider shortage briefing for clinical guidance.

Your diabetes management shouldn't suffer because of supply chain headaches. With the right information and tools, you can stay ahead of the curve.